Tag: Omics Core

Filter

Thought Leadership

Product

Community

Precision Insights
NantHealth Announces FDA Marketing Authorization of Omics CoreSM: The Nation’s First Tumor-Normal Mutation Profiling of Overall Tumor Mutational Burden from...
Landmark FDA clearance of whole exome sequencing in vitro diagnostic (IVD) test reporting overall tumor mutation burden (TMB) by sequencing...
Precision Insights

NantHealth | Technology that Simplifies Healthcare.